Thank you to everyone who participated in the Summit topic selection survey. We received 66 responses, providing valuable feedback to help shape the direction of the PET Drugs Manufacturing Summit.

Following review of the survey results, the Program Committee met and identified several key discussion areas to address during the Summit. Based on participant input, the preliminary program topics currently include:

1. FDA’s Environmental Monitoring Enforcement

2. Incoming Materials Testing

3. Addressing FDA Inconsistency and the Training Level of FDA Reviewers and Inspectors

4. Communicating Risk Assessment and Justification with the FDA

5. External Relationships: Effective Cultivation & Communication

6. Theragnostics

These sessions are being designed as collaborative, solutions-oriented discussions focused on identifying practical paths forward for the PET drugs manufacturing community. Please note that the program is still in preliminary development and topics, session formats, moderators, and timing remain subject to change as planning continues. Additional program details will be posted as they become available.